Loading
Latest filing published 29 May 2026 for Brainstorm Cell Therapeutics INC.. Read the official filing
No signal scores available.
Uri Yablonka is a declared insider of Brainstorm Cell Therapeutics Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 11 March 2024 and the latest from 26 February 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 29 May 2026, reports a share grant in Brainstorm Cell Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations